Protalix BioTherapeutics, Inc. (PLX)

NYSEAMERICAN: PLX · Real-Time Price · USD

1.610

-0.030 (-1.83%)

At close: Aug 13, 2025, 4:00 PM

1.550

-0.060 (-3.73%)

Pre-market: Aug 14, 2025, 8:58 AM EDT

Protalix BioTherapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	59.76	53.4	65.49	47.64	38.35	62.9	Upgrade
Revenue Growth (YoY)	0.18%	-18.47%	37.48%	24.22%	-39.03%	15.00%	Upgrade
Cost of Revenue	29.9	24.32	22.98	19.59	16.35	10.87	Upgrade
Gross Profit	29.87	29.08	42.51	28.05	22	52.03	Upgrade
Selling, General & Admin	11.68	12.19	14.96	11.71	12.73	11.15	Upgrade
Research & Development	13.56	12.97	17.09	29.35	29.73	38.17	Upgrade
Operating Expenses	25.24	25.16	32.05	41.06	42.46	49.32	Upgrade
Operating Income	4.63	3.92	10.46	-13.01	-20.46	2.71	Upgrade
Interest Expense	-0.68	-1.06	-3.18	-2.53	-7.52	-9.67	Upgrade
Interest & Investment Income	1.21	1.3	1.29	1.15	0.4	0.44	Upgrade
EBT Excluding Unusual Items	5.16	4.15	8.57	-14.4	-27.58	-6.52	Upgrade
Pretax Income	5.16	4.15	8.57	-14.4	-27.58	-6.52	Upgrade
Income Tax Expense	1.25	1.22	0.25	0.53	-	-	Upgrade
Earnings From Continuing Operations	3.91	2.93	8.31	-14.93	-27.58	-6.52	Upgrade
Net Income	3.91	2.93	8.31	-14.93	-27.58	-6.52	Upgrade
Net Income to Common	3.91	2.93	8.31	-14.93	-27.58	-6.52	Upgrade
Net Income Growth	-42.93%	-64.73%	-	-	-	-	Upgrade
Shares Outstanding (Basic)	73	73	68	48	44	29	Upgrade
Shares Outstanding (Diluted)	82	81	82	48	44	29	Upgrade
Shares Change (YoY)	-5.05%	-1.66%	70.04%	9.81%	51.43%	96.44%	Upgrade
EPS (Basic)	0.05	0.04	0.12	-0.31	-0.62	-0.22	Upgrade
EPS (Diluted)	0.05	0.04	0.09	-0.31	-0.62	-0.22	Upgrade
EPS Growth	-23.34%	-57.71%	-	-	-	-	Upgrade
Free Cash Flow	-1.56	7.39	-2.47	-25.63	-11.74	-26.76	Upgrade
Free Cash Flow Per Share	-0.02	0.09	-0.03	-0.53	-0.27	-0.92	Upgrade
Gross Margin	49.98%	54.46%	64.91%	58.87%	57.37%	82.71%	Upgrade
Operating Margin	7.74%	7.33%	15.97%	-27.32%	-53.36%	4.31%	Upgrade
Profit Margin	6.54%	5.49%	12.69%	-31.33%	-71.92%	-10.37%	Upgrade
Free Cash Flow Margin	-2.61%	13.84%	-3.77%	-53.80%	-30.62%	-42.55%	Upgrade
EBITDA	5.96	5.22	11.65	-11.93	-19.34	4.01	Upgrade
EBITDA Margin	9.97%	9.78%	17.79%	-25.04%	-50.44%	6.38%	Upgrade
D&A For EBITDA	1.33	1.3	1.19	1.09	1.12	1.3	Upgrade
EBIT	4.63	3.92	10.46	-13.01	-20.46	2.71	Upgrade
EBIT Margin	7.74%	7.33%	15.97%	-27.32%	-53.36%	4.31%	Upgrade
Effective Tax Rate	24.19%	29.42%	2.96%	-	-	-	Upgrade
Revenue as Reported	59.76	53.4	65.49	47.64	38.35	62.9	Upgrade

Updated May 9, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q